Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma

NCT02541643 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Elotuzumab

Sponsor

Sundar Jagannath

Collaborators

[object Object]